Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
19.50
+2.09 (12.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $6.33 billion as of February 21, 2025. Its market cap has increased by 152.55% in one year.
Market Cap
6.33B
Enterprise Value
6.25B
1-Year Change
152.55%
Ranking
Category
Stock Price
19.50
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $6.33B, an increase of 5,389.71%. That is a compound annual growth rate of 73.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |